Literature DB >> 3200368

A clinico-pathological study of herpes simplex encephalitis.

P G Kennedy1, J H Adams, D I Graham, G B Clements.   

Abstract

A retrospective clinical and pathological analysis has been performed of 24 cases of herpes simplex virus encephalitis (HSE) seen at the Institute of Neurological Sciences, Glasgow, between 1972 and 1985. All patients had been diagnosed on the basis of isolation of herpes simplex virus (HSV) from, and/or the demonstration of characteristic histological changes of acute necrotizing encephalitis (ANE) in brain biopsy and/or autopsy tissue. Clinical presentation on admission included a prodromal influenza-like illness (46%), sudden onset of headache and confusion (54%), meningism (38%), deep coma (42%), aphasia (54%) and focal neurological signs (79%). Seizures occurred in 46% of cases during the course of the illness. Of the 24 cases, 14 (58%) died and 10 (42%) survived. Intravenous acyclovir treatment was associated with the best prognosis. Cerebral biopsy of one temporal lobe was performed in 22 cases and in 19 of these a positive histological diagnosis of HSE could be made. HSV was isolated from 15 of the 19 (79%) biopsied cases in whom virus isolation was attempted. Only seven out of the 15 cases (47%) in which immunofluorescence assays for HSV antigens were performed were unequivocally positive. Herpes simplex virus was isolated in culture from all cases which were negative by immunofluorescence. Immunocytochemical analysis on tissue sections of five representative brain biopsies demonstrated the presence of HSV antigens in some astrocytes, neurons and macrophages especially within areas of inflammatory infiltration. In situ hybridization experiments with a cloned HSV DNA probe demonstrated viral RNA in astrocytes, neurons and macrophages in two human biopsies and mouse brains in areas broadly corresponding to the distribution of viral antigen labelling. The combined immunocytochemical and in situ hybridization procedure showed that many but not all of the cells containing viral RNA also contained HSV antigens, indicating a productive infection in these double-labelled cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3200368     DOI: 10.1111/j.1365-2990.1988.tb01141.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  11 in total

1.  Discrimination of herpes simplex virus types 1 and 2 cerebral infections in a rat model.

Authors:  T Bergström; B Svennerholm; N Conradi; P Horal; A Vahlne
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Intravenous infusion of cereport increases uptake and efficacy of acyclovir in herpes simplex virus-infected rat brains.

Authors:  D J Bidanset; L Placidi; R Rybak; J Palmer; J P Sommadossi; E R Kern
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Corticosteroids are unable to protect against pseudorabies virus-induced tissue damage in the developing brain.

Authors:  Amanda C Clase; Bruce W Banfield
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice.

Authors:  P Sundaresan; W D Hunter; R L Martuza; S D Rabkin
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 5.  Herpes Simplex Encephalitis: an Update.

Authors:  John W Gnann; Richard J Whitley
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

6.  Burden of herpes simplex virus encephalitis in the United States.

Authors:  S Modi; Abhimanyu Mahajan; D Dharaiya; P Varelas; P Mitsias
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

7.  Resistance of rat CNS to brain stem infection with herpes simplex virus type 1.

Authors:  T Bergström; N Conradi; E Hansson; A Liljeroth; A Vahlne
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates.

Authors:  Justin C Roth; Kevin A Cassady; James J Cody; Jackie N Parker; Kathleen H Price; Jennifer M Coleman; James O Peggins; Patricia E Noker; Nicholas W Powers; Sheila D Grimes; Steven L Carroll; G Yancey Gillespie; Richard J Whitley; James M Markert
Journal:  Hum Gene Ther Clin Dev       Date:  2014-03       Impact factor: 5.032

9.  Increased level of compleasomes in cerebrospinal fluid of patients with herpes simplex encephalitis.

Authors:  Ewa Johansson; Stefan Lange; Tomas Bergström; Merna Oshalim; Ivar Lönnroth; Marie Studahl
Journal:  J Neurovirol       Date:  2018-08-09       Impact factor: 2.643

10.  An improved animal model for herpesvirus encephalitis in humans.

Authors:  Julia Sehl; Julia E Hölper; Barbara G Klupp; Christina Baumbach; Jens P Teifke; Thomas C Mettenleiter
Journal:  PLoS Pathog       Date:  2020-03-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.